PACI, SABRINA
 Distribuzione geografica
Continente #
EU - Europa 3.551
NA - Nord America 2.141
AS - Asia 1.133
SA - Sud America 63
OC - Oceania 14
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 6.919
Nazione #
US - Stati Uniti d'America 2.052
GB - Regno Unito 1.264
IT - Italia 871
CN - Cina 537
SE - Svezia 424
DE - Germania 280
SG - Singapore 182
TR - Turchia 173
RU - Federazione Russa 133
FR - Francia 130
KR - Corea 102
IE - Irlanda 98
UA - Ucraina 98
CA - Canada 82
EU - Europa 80
FI - Finlandia 71
IN - India 56
NL - Olanda 54
HK - Hong Kong 43
CO - Colombia 37
DK - Danimarca 31
BE - Belgio 27
BR - Brasile 22
GR - Grecia 18
PL - Polonia 15
AU - Australia 13
ID - Indonesia 12
CH - Svizzera 8
UZ - Uzbekistan 8
VN - Vietnam 8
EG - Egitto 7
MX - Messico 6
CZ - Repubblica Ceca 4
ES - Italia 4
IL - Israele 3
IR - Iran 3
IS - Islanda 3
RO - Romania 3
RS - Serbia 3
SM - San Marino 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
JP - Giappone 2
NG - Nigeria 2
NO - Norvegia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
EC - Ecuador 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
ZA - Sudafrica 1
Totale 6.994
Città #
Southend 1.184
Chandler 302
Milan 184
Seattle 158
Beijing 155
Princeton 138
Singapore 117
Wilmington 101
Ann Arbor 100
Dublin 93
Redmond 87
Mountain View 79
Toronto 75
Nanjing 68
Somerville 68
Jacksonville 66
Ashburn 64
Hanover 59
Fairfield 51
Des Moines 49
Boardman 45
Sakarya 44
Hong Kong 42
Dearborn 40
Woodbridge 40
Andover 39
Bogotá 37
Bengaluru 35
Serra 35
Houston 32
Rome 29
Frankfurt am Main 25
Jinan 25
Redwood City 25
Phoenix 24
Shenyang 24
Shanghai 23
Roxbury 22
Tianjin 22
Cambridge 20
Brussels 18
Nanchang 18
Guangzhou 17
Medford 17
Athens 15
Hebei 14
Torino 14
Santa Clara 12
Sunnyvale 12
Warsaw 12
Changsha 11
Istanbul 11
Odernheim 11
Turin 11
Bitonto 10
Helsinki 10
Berlin 9
Jiaxing 9
Eitensheim 8
San Diego 8
Settimo Torinese 8
Zhengzhou 8
Corsico 7
Fuzhou 7
Padova 7
Prato 7
Trieste 7
Varese 7
Chatsworth 6
Florence 6
Hangzhou 6
New York 6
Verona 6
Al `Amiriyah 5
Falls Church 5
Hamburg 5
Naples 5
Ottawa 5
Palermo 5
Belo Horizonte 4
Bergamo 4
Castiglione del Lago 4
Dong Ket 4
Ferrara 4
Geisenheim 4
Genoa 4
Grafing 4
Jakarta 4
Messina 4
Mumbai 4
Napoli 4
Taizhou 4
Belgrade 3
Capriolo 3
Catania 3
Chiari 3
Columbus 3
Ercolano 3
Fremont 3
Geelong 3
Totale 4.267
Nome #
Gammapatia monoclonale in glicogenosi Ib (GSD Ib): case report 244
Cataract and optic disk drusen in a patient with glycogenosis and di George syndrome: Clinical and molecular report 212
Breastfeeding in phenylketonuric (PKU) and hyperphenylalaninemic (HPA) infants : how and why 202
Sostituti proteici a base di aminoacidi vs glicomacropeptide: accettabilità e palatabilità in pazienti fenilchetonurici 200
Could neurological symptomatology precede an acute metabolic crisis in patient affected by propionic aciduria (PA)? A particular case report 163
Assetto lipidico nei pazienti con glicogenosi: l'esperienza della Clinica Pediatrica dell'Ospedale San Paolo 159
Diagnosi differenziale delle linfoadenopatie 152
Treating Phenylketonuria : a single centre experience 147
Quando la chetonuria nel lattante è spia di malattia metabolica 146
Breastfeeding in phenylketonuric and hyperphenylalaninemic infants : how and why 143
Exploring drivers of liking of low-phenylalanine products in subjects with phenyilketonuria using check-all-that-apply method 143
Absence of severe recurrent infections in GSD IB 133
Lens opacities in glycogenoses type i and III 132
Use of fibroscan in monitoring liver impairment in glycogen storage disease type I and III 130
Densità minerale ossea (BMD) nei pazienti affetti da iperfenilalaninemia (HPA): ruolo della supplementazione con calcio e dell'attività fisica 129
Bone mineralization in type 1 glycogen storage disease: a two years follow up study 126
Mineralizzazione ossea in pazienti con GSD 1. e 3. 124
Amino acid status 6 hours after the assumption of two amino acid preparations in PKU patients on diet-therapy 124
Disease natural history in a large group of genetically diagnosed glycogen storage disease type III. 123
Docosahexaenoic acid through childhood: functional role, metabolic association and therapeutic effects 123
Bone metabolism and hypovitaminosis D in patients affected by glycogen storage disease type I (GSD I) 119
A case of glycogenosis type IB associated with MGUS 119
Bone mineralization in GSD I and III 117
Case report: GSD type 1. and pregnancy 117
Cardiovascular risk factors in hyperphenylalaninemic children on dietary treatment : correlation between carotid intima-media thickness and docosaexahenoic acid supplementation 116
Phenylketonuria : nutritional advances and challenges 115
Bone mineral density (BMD) in patients affected by hyperphenylalanynemia (HPA) : effects of calcium integration and physical activity evaluated with dual energy x-ray absorptiometry (DEXA) 113
Heart disease and inborn errors of metabolism: prevalence, manifestations and correlation with the specific ongoing treatment in 42 patients followed at San Paolo Hospital, Milan 113
Acidi grassi polinsaturi a lunga catena (LCPUFA) 112
Thyroid and glycogenosis 110
Un caso caratterizzato da macchie caffè-latte 110
Glicogenosi tipo 1. : dieta e salute dell’osso 109
Psychosocial distress in PKU female patients with good and bad metabolic control 109
Psychosocial distress in PKU female patients with good and bad metabolic control 109
Hyperphenylalaninemia and potential renal acid load (PRAL) 108
Il trattamento con vitamina E migliora la neutropenia e riduce la frequenza di infezioni nei pazienti con glicogenosi tipo 1b 107
Diagnosticare la malattia di Fabry per curarla 102
Ipertransaminasemia da indagare in lattanti extra-comunitari 101
Is phenylalanine (Phe) loading test still necessary for hyperphenylalaninemia patient with basal plasma level < 360 micromol/l? 100
Bone mass density and body composition measured with dexa in patient affected by hyperphenilalaninemia 99
Determinants of Plasma Docosahexaenoic Acid Levels and Their Relationship to Neurological and Cognitive Functions in PKU Patients: A Double Blind Randomized Supplementation Study 98
Severe PRPS Deficienty in an Adult Lawyer with Normal IQ 97
Evaluation of phenylalanine brain metabolism in three adult patients affected by PKU through magnetic resonance spectroscopy after six months of supplementation with LNAA 97
Malattie metaboliche 97
Nutritional indices and polyunsaturated fatty acids in PKU patients at 20 days of life 95
Le glicogenosi non sono solo malattie dei glucidi 94
Un episodio di febbre elevata in un lattante di quattro mesi con tosse a alvo diarroico 93
Patologia responsabili di ipertransaminasemia 92
Un quadro clinico disturbato da episodi di sopore e vomito 91
PKU in Italy 90
Un caso complesso di metabolismo del rame alterato 88
Resting energy expenditure in patients affected by glicogen storage disease type I and III 87
Fourty years of nutritional follow-up in PKU patients 87
Iperfenilalaninemie : Raccomandazioni diagnostiche, therapeutiche ed assistenziali 87
Genotype, basal PHE levels and type of nourishment as predictive factors of the BH4 loading test response in phenylketonuria (PKU) affected patients 87
Una patologia d’accumulo associata a crisi ipoglicemiche 85
La pre-eclampsia: implicazioni materne e feto-neonatali 84
Efficacy of enzyme replacement therapy over six-months in a non-classic infantile Pompe disease form: our experience in a 2-year-old affected child 83
Maternal PKU and heterozygous women for hyperphenylalaninemia (HPA) : what is the outcome for issue? 79
Evaluation of bone mass density and body composition measured with DEXA in patient affected by hyperphenylalaninemia 77
Maternal PKU and heterozygous women for hyperphenylalaninemia (HPA) : what is the outcome for the offspring? 74
La cataratta congenita 73
Pre-diagnosis weight increase and phenylalanine levels in PKU patients 64
Erythrocyte Galactose-1-phosphate measurement by GC-MS in the monitoring of classical galactosemia 60
Severe PTPS deficiency in an adult lawyer with normal IQ 57
Parents' experience of the communication process of positivity at newborn screening for metabolic diseases: A qualitative study 40
Totale 7.416
Categoria #
all - tutte 19.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020604 0 0 0 55 37 76 44 73 115 157 28 19
2020/2021799 26 50 106 14 79 54 39 41 95 59 206 30
2021/2022732 76 16 91 16 34 36 78 16 99 49 31 190
2022/2023987 107 109 110 107 121 182 26 54 108 20 31 12
2023/2024503 20 64 41 17 134 14 16 24 8 29 74 62
2024/2025264 78 153 27 6 0 0 0 0 0 0 0 0
Totale 7.416